BERLIN, March 30 (Reuters) - Germany will restrict the use
of AstraZeneca's COVID-19 vaccine to people aged 60 and
over and high-priority groups, Chancellor Angela Merkel said on
Tuesday.
The move, agreed with the 16 federal states, follows the
recommendation of the independent vaccine committee and comes in
response to new reports of a rare brain blood disorder and could
turn out as a severe setback to the country's vaccination
campaign.
"Everything is based on one principle and that is trust,"
Merkel said at a news conference. "Confidence arises from the
knowledge that every suspicion is counted in every individual
case."
(Reporting by Paul Carrel; Writing by Kirsti Knolle; Editing by
Maria Sheahan)